Clinical trial

Saxagliptin Triple Oral Therapy

NCT01128153

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-01

PhasePHASE3

Study timeline

Study start (unknown)2010-06-01Date precision: month

Registry last updated2012-08-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

SaxagliptinDRUG · verified · RxNorm: saxagliptin

PlaceboDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Bristol-Myers Squibbcollaborator

Mapped research locations

SeoulSouth Korea1 MelbourneVictoria, Australia1 GlasgowUnited Kingdom1 BangkokThailand1 DaeguSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01128153 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.